Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 55Prostatic Neoplasms 46Glioblastoma 28Brain Neoplasms 25Neoplasms 23Glioma 20Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 18Carcinoma, Hepatocellular 14Gliosarcoma 13Colorectal Neoplasms 12Uterine Cervical Neoplasms 11Neoplasm Metastasis 11Rectal Neoplasms 10Lymphoma, Non-Hodgkin 10Oligodendroglioma 9Melanoma 9Central Nervous System Neoplasms 9Astrocytoma 9Lymphoma 8Head and Neck Neoplasms 8Esophageal Neoplasms 8Colonic Neoplasms 8Ependymoma 7Squamous Cell Carcinoma of Head and Neck 6Pancreatic Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Carcinoma, Renal Cell 6Breast Neoplasms, Male 6Ovarian Neoplasms 5

Interventions

pembrolizumab 2Imatinib Mesylate 2Cisplatin 2Axitinib 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2tislelizumab 1regorafenib 1gallium 68 PSMA-11 1avelumab 1Tretinoin 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Nelfinavir 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Immunotherapy 1GSK-3326595 1Everolimus 1Etoposide 1Endoscopic Mucosal Resection 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1Blood Specimen Collection 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Adenoid Cystic × Magnetic Resonance Spectroscopy × Clear all
NCT06521775 2025-09-12

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma

Mayo Clinic

Phase 2 Completed
6 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡